 MELBOURNE, Australia, April 12, 2021 GLOBE NEWSWIRE -- Molecular diagnostics company Genetic Technologies Limited ASX: GTG; NASDAQ: GENE, Company, announces the appointment of Michael Tonroe to the role of Chief Financial Officer, commencing on 28 June 2021. 